Screener
Context Therapeutics Inc. CNTX Q4 2025 Annual earnings
Reported March 19, 2026 · Before market open
EPS-$0.14Miss by $0.03
Revenue estimate-$1.5M
EPS estimate-$0.11
Next report
Nov 4, 2026 (in 2 months)EPS estimate-$0.09
Versus estimates
Diluted EPS
FAQ
- When did Context Therapeutics Inc. report Q4 2025 earnings?
- Context Therapeutics Inc. (CNTX) reported Q4 2025 earnings on March 19, 2026 before market open.
- What were Context Therapeutics Inc.'s Q4 2025 revenue and EPS?
- Context Therapeutics Inc. reported eps of $-0.14 for Q4 2025.
- Did Context Therapeutics Inc. beat estimates in Q4 2025?
- EPS missed the consensus estimate of $-0.11 by $0.03.
- How did Context Therapeutics Inc.'s Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 250.0% from $-0.04.
- Where can I find Context Therapeutics Inc.'s Q4 2025 SEC filings?
- You can read the 10-K periodic report (0001628280-26-020498) directly on SEC EDGAR. The filing index links above go to sec.gov.
